Last reviewed: June 21, 2026
Last updated: June 21, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes, has demonstrated significant weight loss benefits in clinical trials, with participants losing up to 22% of body weight over 68 weeks. Finding legitimate, affordable semaglutide requires knowing the difference between retail pharmacies, telemedicine platforms, and licensed compounding options. PlexusDx offers a transparent pathway to compounded semaglutide through licensed 503A pharmacies, with pricing that remains flat regardless of dose adjustments.
Start your GLP-1 program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.
Start your intake →
Understanding Semaglutide Availability and Sources
Semaglutide is available through several channels: brand-name Ozempic or Wegovy from retail pharmacies with insurance, private pay at pharmacy pricing (typically $900–$1,500 monthly), telemedicine providers with variable pricing, and licensed compounding pharmacies offering lower-cost alternatives. Brand-name medications often come with insurance restrictions, prior authorization requirements, and substantial out-of-pocket costs for uninsured patients. Compounded semaglutide from licensed 503A pharmacies provides a legal, regulated alternative that maintains the same active ingredient and clinical mechanism as brand products.
PlexusDx sources compounded semaglutide exclusively from licensed 503A compounding pharmacies, which operate under strict FDA oversight and state pharmacy board regulations. These facilities compound medications to individual specifications, allowing for personalized dosing and lower pricing compared to mass-manufactured brand products. All compounded medications are prepared to pharmaceutical-grade standards, and patients receive detailed information about their source pharmacy and compounding process.
Why Compounded Semaglutide Costs Less Than Brand Options
Brand-name Ozempic and Wegovy carry substantial manufacturing, marketing, and distribution costs that are reflected in retail pricing. Pharmaceutical companies invest billions in drug development and regulatory approval, costs passed to consumers through brand pricing. Compounded semaglutide achieves cost efficiency by preparing doses on-demand in licensed pharmacies, eliminating mass manufacturing overhead while maintaining identical active pharmaceutical ingredients and sterile preparation standards.
PlexusDx's compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan), with your dose able to increase during treatment without price changes. This flat-rate pricing model means patients know their monthly cost upfront, whether starting at lower doses for tolerance or advancing to therapeutic maintenance doses. No hidden dose-escalation fees, no membership requirements, and no insurance copays—just transparent monthly pricing accessible to all 50 states.
How to Access Semaglutide Through PlexusDx
PlexusDx makes semaglutide access straightforward: complete an online health intake form, connect with a licensed provider for medical review, receive a personalized prescription, and have your medication shipped directly to your home. The entire process takes days rather than weeks, and patients can begin treatment quickly without insurance delays or prior authorization battles. PlexusDx accepts HSA and FSA accounts, making compounded semaglutide eligible for pre-tax health savings.
After your first month on treatment, patients may opt for the Precision Peptide Genetic Test ($298), which analyzes 14 metabolic pathways and 49 peptides to identify genetic predispositions affecting weight loss response. This test examines key variants in semaglutide response genes like GIPR rs1800437, providing data to help optimize your therapy choice and dosing strategy. Genetic insights guide decisions about staying with semaglutide, switching to tirzepatide, or exploring combination approaches.
Comparing Semaglutide to Other GLP-1 Weight Loss Options
Semaglutide is a single-action GLP-1 receptor agonist, meaning it stimulates one receptor pathway to reduce appetite and improve blood sugar control. Tirzepatide, by contrast, acts as a dual GLP-1 and GIP receptor agonist, engaging two metabolic pathways simultaneously and producing greater average weight loss in head-to-head trials. Oral semaglutide is available as an alternative to injections but requires fasting conditions and comes at higher monthly costs ($289/month with PlexusDx) due to lower bioavailability.
PlexusDx offers compounded semaglutide injections ($189/mo), oral semaglutide ($289/mo), compounded tirzepatide injections ($289/mo), and GLP-Squared dual compounds combining semaglutide and tirzepatide ($289/mo injection). Your choice depends on genetic predispositions revealed by the Precision Peptide Genetic Test, personal tolerance of injections, and response goals. Patients who begin with semaglutide and achieve partial response may transition to tirzepatide or combination therapy without restarting at new-patient pricing.
Safety, Legitimacy, and Quality Assurance
Licensed 503A compounding pharmacies operate under state board of pharmacy oversight and FDA guidances for pharmaceutical compounding, ensuring sterility, potency, and purity equivalent to brand medications. PlexusDx partners only with established 503A facilities with demonstrated compliance records and quality assurance protocols. Compounded medications are not FDA-approved as discrete products, but the active pharmaceutical ingredient (semaglutide) is FDA-approved, and the compounding process is federally regulated.
Patients should verify their compounding pharmacy's licensure and accreditation through their state pharmacy board website. PlexusDx provides full transparency about source pharmacies and includes batch testing documentation with each shipment. Common side effects of semaglutide—nausea, vomiting, constipation, diarrhea—are dose-dependent and typically resolve within weeks as the body adjusts; serious adverse events are rare but require immediate medical attention and communication with your PlexusDx provider.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.
Frequently Asked Questions
Can I buy semaglutide online without a prescription?
No, semaglutide requires a valid prescription from a licensed healthcare provider, whether you purchase from a retail pharmacy or through PlexusDx. PlexusDx connects you with licensed providers who review your medical history and issue personalized prescriptions within days, ensuring safe, legal access.
How much weight can I expect to lose on semaglutide?
No — the Precision Peptide Genetic Test does not predict your response to Ozempic or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.
Is PlexusDx semaglutide the same as brand-name Ozempic or Wegovy?
PlexusDx semaglutide contains the identical active ingredient as Ozempic and Wegovy, but is compounded by licensed 503A pharmacies rather than mass-manufactured by the brand company. The medication works identically; the main differences are cost ($149/mo vs. $900–$1,500/mo), no insurance required, and flat pricing across all dose levels.
What are the side effects of semaglutide, and how common are they?
Most common side effects are gastrointestinal: nausea (25–32% of users), vomiting, constipation, and diarrhea. These typically appear in the first 1–2 weeks and resolve as your body adjusts. Serious side effects like pancreatitis or thyroid issues are rare but require immediate medical attention; inform your PlexusDx provider of any concerning symptoms.
How does the Precision Peptide Genetic Test help my semaglutide treatment?
No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Is It Safe to Switch from Wegovy to Zepbound?
Combining Mounjaro and Metformin: A Path to Enhanced Metabolic Health